The advantages of such an approach may be its better suitability for sampling a comprehensive tumor profile and detecting HER2 status throughout the primary tumor and any metastases, compared to limited tissue sampling with biopsies restricted to specific locations within GC lesions [40]. The gene discussed is ERBB2; the disease is gastric cancer.